Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/24/23 09:03 | 4/21/23 | GNPX | Health | Drug | Pharmaceutical Preparations | Varner John Rodney | TX | DO | CB,P,CEO | P | 20 | 1.06 | 0 | 19 | 2 | 1,181 | I | ||||||||||||||
4/24/23 09:00 | 4/21/23 | GNPX | Health | Drug | Pharmaceutical Preparations | Vaczy Catherine M | TX | O | EVP GC C | P | 21 | 1.07 | 0 | 20 | 8 | 265 | D | ||||||||||||||
4/7/21 16:41 | 4/5/21 | GNPX | Health | Drug | Pharmaceutical Preparations | Longnecker Brent M | TX | D | P | 62 | 4.15 | 0 | 15 | 75 | 35 | D | |||||||||||||||
9/9/19 13:11 | 9/5/19 | GNPX | Health | Drug | Pharmaceutical Preparations | Varner John Rodney | TX | DOT | CEO | P | 2 | 0.8859 | 0 | 2 | 0 | 2,161 | I | ||||||||||||||
8/2/18 16:59 | 7/30/18 | GNPX | Health | Drug | Pharmaceutical Preparations | Pham Julien L | TX | O | P,COO | P | 2 | 3.40 | 0 | 1 | New | 1 | D | ||||||||||||||
4/5/18 16:57 | 3/29/18 | GNPX | Health | Drug | Pharmaceutical Preparations | Varner John Rodney | TX | DOT | CEO | P.d | 50 | 5.00 | 0 | 10 | 0 | 2,159 | D | ||||||||||||||
4/5/18 16:51 | 3/29/18 | GNPX | Health | Drug | Pharmaceutical Preparations | Roth Jack A | TX | T | P | 200 | 5.00 | 0 | 40 | 2 | 2,389 | I | |||||||||||||||
4/5/18 16:46 | 3/29/18 | GNPX | Health | Drug | Pharmaceutical Preparations | Nance Christy M. | TX | T | P.d | 250 | 5.00 | 0 | 50 | 2 | 3,006 | D |
D | Derivative transaction in filing (usually option exercise) |
M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
A | Amended filing |
E | Error detected in filing |
S - Sale | Sale of securities on an exchange or to another person |
S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
P - Purchase | Purchase of securities on an exchange or from another person |